Get started

Stockmarkets

Why Qudian Stock Popped higher in 2021?Why Qudian Stock Popped higher in 2021? On Dec 30, 2020 in Brussels, European Union negotiators finalized the terms of a historic investment agreement with China. Seven years in the making, the new Comprehensive Agreement on Investment is expected to grow international trade between the EU and China, facilitate cross-border investment, and "strongly stimulate" the economies of both nations, according to Chinese president Xi Jinping. CNN highlighted the financial services sector, electric vehicles, and healthcare as three areas of the Chinese economy likely to benefit especially from the trade accord. Don't expect to see immediate benefits for Qudian Stock, however. Just because negotiators have signed the deal doesn't mean that their respective legislatures will ratify it, and the Comprehensive Agreement can't go into effect before that happens. According to FT, EU officials are targeting an effective date for the agreement no earlier than 2022. www.fool.com
NYSE:QD
by AlenCiken
ALDX Announces Positive Top-Line Symptom and Sign ResultsAldeyra Therapeutics Announces Positive Top-Line Symptom and Sign Results from Run-In Cohort of Phase 3 TRANQUILITY Trial in Dry Eye Disease Statistical Significance of Reproxalap Over Vehicle Achieved for Ocular Redness, an FDA-Approvable Sign, and Clinical Symptoms of Ocular Dryness and Discomfort Acute Improvement in Ocular Redness and Symptom Scores Demonstrated Within Minutes of Reproxalap Administration in Dry Eye Chamber Main Cohort of TRANQUILITY Expected to Begin Enrollment in February 2021, Following Completion of Tear RASP Analysis and Finalization of Trial Design finance.yahoo.com
NASDAQ:ALDX
by AlenCiken
Why CNET 3D-Printing Stock Soared YesterdayShares of 3D-printing companies rose sharply on Thursday after 3D Systems (NYSE:DDD) reported blockbuster preliminary results for the fourth quarter. This news has given investors hope that other companies in the sector will report similarly strong results. in the first three quarters of 2020, Stratasys's total revenue fell by more than 20% year over year. The strong preliminary results from 3D Systems are sparking investor optimism that the 3D-printing industry is about to come roaring back as manufacturing activity picks up and economies start to recover from the havoc caused by the pandemic. www.fool.com
NASDAQ:SSYS
by AlenCiken
Completes Sale of Cimatron and GibbsCAM Businesses3D Systems Completes Sale of Cimatron and GibbsCAM Businesses and Provides Preliminary Financial Results for Fourth Quarter 2020 - Announces Date of Fourth Quarter and Full Year 2020 Financial Results - Close of sale of non-core software businesses for cash proceeds of approximately $64 million - Repayment of all debt outstanding under senior secured term loan. With the paydown of the term loan, the company is now free of any outstanding debt but continues to have availability under its senior secured revolving credit facility, which remains fully undrawn at this point. - Official termination of ‘At-the-Market’ Equity Offering Program - Strong Q4 preliminary financial performance with expected revenues between $170 million and $176 million - Expected revenue reflects strong organic growth exceeding 20% in both Healthcare and Industrial business units on a consecutive quarter basis. Essentially debt-free now, and free to focus on its two core 3D printer making businesses (industrial and healthcare), the company also noted that in addition to the better-than-expected sales, it is likely to report anywhere from $11 million to $19 million in pro forma profit for Q4. Generally accepted accounting principles (GAAP) results could still be as bad as an $8.6 million loss, but there's at least the possibility that 3D will eke out a GAAP profit of as much as $0.5 million this quarter. finance.yahoo.com
NYSE:DDD
by AlenCiken
“Strong Buy” Penny Stock That Could Deliver Massive Returns“Strong Buy” Penny Stock That Could Deliver Massive Returns The company’s development pipeline features drug candidates under investigation as treatments for short bowel syndrome (SBS) and celiac disease (CeD), two conditions that are both dangerous and difficult to treat. 9 Meters’ flagship product, Larazotide, is in Phase 3 development for the treatment of CeD. CeD affects about 1% of the population, yet there are no approved therapies. Top-line data from the study is expected in the second half of 2021. this past December, the company announced that it had entered an agreement with EBRIS, the European Biomedical Research Institute of Salerno, to investigate Larazotide as a potential treatment for respiratory complications due to COVID-19. The other major drug in the company’s pipeline is NM-002, for SBS. The company has recently announced positive Phase 1b/2a results, with a measurable impact on disease symptoms from a compound that was well-tolerated by patients. finance.yahoo.com
N
by AlenCiken
"Blue Wave" A Black Swan Event? Stock Market Drop!Wild day on Wall Street. The S&P 500, the Nasdaq, the Dow Jones all did finish lower, but WELL off the lows. Last week, I mentioned how this week would be big with the Georgia (GA) Senate run off and then the December 6th Electoral College vote. The GA Senate run is the big one. If the Democrat Candidates win both seats tomorrow, the Senate is split 50-50 between the Democrats and the Republicans, but the Vice President gets the determining vote, and since that person is a Democrat, the Democrats technically take the Senate. This means that they can pass the programs that they want. The current set up, with a Democratic President and a Republicans controlled Senate is the Goldilocks zone. Balance and checks remain so the Democrats cannot pass large programs. "Strikingly, while online betting markets priced in a relatively modest 25-30% probability of a blue sweep (i.e., Democrats winning both GA runoffs tomorrow), the Predictit odds for a "blue wave" have soared in the past few days, surging just shy of 50%." In fact, we went slightly above 50% today. To me, this would meet the definition of a Black Swan Event. Something the market is NOT pricing in. So there is a possibility we drift lower given the outcome tomorrow (perhaps market pricing this in NOW). Just want to be clear: this is not telling us the Dems win the Senate tomorrow, it is just a possibility that the markets are fearing and reacting to. If the Republicans maintain the Senate, markets will continue their uptrend as we remain in the Goldilocks zone. If we get the Dem outcome, we can continue a move lower. The zones I would look at would be on the Daily chart. For the S&P, there is a possibility we are forming a head and shoulders reversal pattern. The 3640 is a major support zone that I am watching if price drops lower. One can make a case there is a flip zone at 3700, and the daily close is indeed closing back above. If we do hit 3640, expect a bounce and then our right shoulder eventually breaking below 3640. That would be my short trigger. I would target 3530, and then 3400 below that. BUT you all know my outlook on the monetary and fiscal side. Cheap and easy money is here to stay. It cannot stop and it will not stop. So yes, there is a chance the S&P 500 and other US Stock Markets drop on the "Blue Wave", but I do think the dip eventually gets bid up. The Federal Reserve is not stopping its asset purchasing program anytime soon. Interest Rates will be suppressed, and stock markets will continue to be the only place to go for yield. A Blue Wave means even MORE money will be spent. Democrats are generally big spenders. Stock markets continue to be the only place to go for real yield. You all know my thoughts on Gold, Silver and Cryptocurrency. This is where you want to be to preserve purchasing power! Expect a highly volatile week. At the end of the week, I would not be surprised to see the tone change. What started as a red week on wall street, turns to be a positive week for wall street. I welcome this relief rally, and further pressure if it plays out. Profits must be taken and the markets need to give back some!
OANDA:SPX500USD
by Uncharted-FX
5
Watching quotients can give a good edge about the market This time is AMEX:SPY / AMEX:UST which compares the U.S. stock market with the U.S. bond market. So, right now is heading to test a very strong resistance in 5.20 points, while for the last few weeks is been divergent from its RSI, all "selling signals". Normally when this quotient gives this signals is because the stock market is losing strength and a correction is on the way because the "smart money" is selling stocks to buy bonds. There's no way to predict how strong could be the correction or even if it will happen, the best thing you could do is to rise stop-loss, sell extended stocks and low stock positions. That is what I have been doing.
AMEX:SPYShort
by dpuleo19
LOAC Announces Signing of Definitive Merger AgreementLongevity Acquisition Corporation Announces Signing of Definitive Merger Agreement 4D pharma's Live Biotherapeutic Products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut. The Company has six clinical programs At the effective time of the merger, each of LOAC's ordinary shares issued and outstanding prior to the effective time of the merger will be automatically converted into the right to receive certain per share merger consideration, and each warrant to purchase LOAC's ordinary shares and right to receive LOAC's ordinary shares that is outstanding immediately prior to the effective time of the merger will be assumed by 4D pharma and automatically converted into a warrant to purchase ordinary shares of 4D pharma and a right to receive ordinary shares of 4D pharma, payable in 4D pharma ADSs, respectively. www.prnewswire.com
L
by AlenCiken
Cano Health to Become Publicly Traded via Merger with JWSCano Health, a Leading Value-Based Care Delivery Platform for Seniors, to Become Publicly Traded via Merger with Jaws Acquisition Corp. - Transaction values Cano Health at an enterprise value of $4.4 billion and is expected to provide up to $1.49 billion in cash proceeds, including a fully committed PIPE of $800 million - PIPE led by $50 million investment from Barry Sternlicht, Chairman of Jaws, as well as commitments from funds affiliated with Fidelity Management & Research Company, funds and accounts managed by BlackRock, Third Point and Maverick Capital Cano Health provides value-based care for more than 103,000 members through its network of 564 primary care physicians across 14 markets in Florida, Texas, Nevada and Puerto Rico. The Company is expected to receive up to $935 million in transaction proceeds to pay down debt and provide growth capital, and a substantial majority of up to $465 million of proceeds is expected to be allocated to Cano Health's financial sponsor. The transaction is expected to close at the end of the first quarter or the beginning of the second quarter of 2021. finance.yahoo.com
J
by AlenCiken
Air T, Inc. Announces Intent to Form New Aircraft Equity VehicleAir T, Inc. Announces Intent to Form New Aircraft Equity Vehicle AIRT) announced today that it has entered into letters of intent with three separate, large investment and asset management firms (the "Investors") to form a new aircraft asset management business to be called Contrail Aircraft Management ("CAM"), and a new aircraft capital joint venture to be called Contrail Fund II ("CFII"). The parties presently expect the new business and joint venture to be formed and capitalized by the end of January 2021. The new business and joint venture are being formed to purchase and sell aircraft and engines to be relet or disassembled and sold for parts. The parties anticipate that CFII will be capitalized initially with approximately $108,000,000 in equity capital and that it will establish a portfolio of aircraft assets, focusing on whole aircraft and engine acquisitions, sale-leaseback transactions and end of life part-out solutions. The capital contributed by the Investors -- presently anticipated to be approximately $100,000,000 -- will be contributed into CFII. The Upsize Commitment is anticipated to exceed $250,000,000. Contrail intends to contribute approximately $8,000,000 of the initial capital committed to the fund as well, which is anticipated to lead to returns alongside the other investors. finance.yahoo.com
NASDAQ:AIRT
by AlenCiken
Eos Energy Secures Contract valued at $2 millionEos Energy Secures Contract to provide Safe, Sustainable Storage to California Hospital Eos Energy Enterprises, Inc. (NASDAQ: EOSE) (“Eos”), today announced it has a firm order from Charge Bliss, Inc. (“CBI”), a renewable energy microgrid developer/builder, to provide a critical care hospital with 2 MW of energy storage using its Znyth® battery. The deal is valued at $2 million. “We are proud to collaborate with Charge Bliss to provide safe and reliable storage for a hospital micro grid application,” Eos will provide this groundbreaking project with up to 2 MW of continuous power delivery upon installation, which is scheduled to take place in the second quarter of 2021. “Our microgrid systems are engineered to supply clean energy while reducing peak demand,” finance.yahoo.com
NASDAQ:EOSE
by AlenCiken
Expected net revenue increasedFourth quarter 2020 net revenue is expected to be approximately $3.5 million, increased from the prior expectation of approximately $2.5 million Received communication from the FDA explaining the reallocation of agency resources to address Emergency Use Authorization (EUA) applications for products related to the COVID-19 public health emergency is affecting marketing application reviews, including the Eversense 180-day product, which will be delayed by at least 60 days. This is consistent with what Senseonics understands other medical technology companies have reported. Inclusion of Eversense Category III CPT codes in the Centers for Medicare & Medicaid Services (CMS) 2021 Physician Fee Schedule (PFS), establishing global payment for the device cost and procedure fees for healthcare providers across the United States Full year 2021 net revenue is expected to be between $12 and $15 million, based on installed base, acceleration of Ascensia’s commercial activities and other factors Reached agreement with Roche to facilitate transition of distribution to Ascensia, as Roche sales conclude January 31, 2021, including final purchases, transition support activities, and resolution of other matters Highbridge second lien loan extinguished through completed conversion of their second lien debt to common stock, simplifying capital structure "Strong fourth quarter performance was driven by sales in Europe and supported by Ascensia’s initial US sales." We remain confident that the PROMISE study demonstrates that the excellent performance of the current Eversense system is extended for up to 180 days, and that there still is potential for a decision from the agency by the end of the end of the second quarter finance.yahoo.com
AMEX:SENS
by AlenCiken
1
ION Acquisition Soars on Taboola SPAC Merger RumorsION Acquisition Soars on Taboola SPAC Merger Rumors IACA stock’s October initial public offering raised $225 million for the special purpose acquisition company (SPAC) focusing on the Middle East region. Its stated goal was a merger with a private company valued at more than $1 billion. That IPO was upsized by more than 10% to 22.5 million units ahead of the floatation. Both ION and Taboola are based in Israel. Daily Haaretz reported on Monday that Taboola was mulling either a SPAC merger or its own IPO. Its sister publication, business daily TheMarker, on Tuesday reported the ION-Taboola negotiations. investorplace.com
I
by AlenCiken
Ouster to Combine With Colonnade Acquisition CorpOuster, a Leading Provider of High-Performance Digital Lidar Sensors, to Combine With Colonnade Acquisition Corp. to Accelerate Digital Lidar Adoption in Industrial, Smart Infrastructure, Robotics, and Automotive Markets. Transaction expected to provide up to $300 million in gross proceeds, comprised of Colonnade Acquisition Corp.’s $200 million of cash held in trust (assuming no redemptions) and a $100 million fully committed common stock PIPE at $10.00 per share, including from Ouster’s existing investors, Cox Enterprises, Fontinalis Partners, and WWJr Enterprises. Pro forma implied enterprise value of ~$1.6 billion and fully diluted pro forma equity value of ~$1.9 billion Ouster shareholders will roll 100% of their equity holdings into the combined company The boards of directors of both Ouster and Colonnade have unanimously approved the proposed business combination, which is expected to be completed in the first half of 2021, subject to, among other things, the approval by Colonnade's shareholders and Ouster’s shareholders, satisfaction of the minimum cash condition, which is equal to the $100 million committed common stock PIPE investment at $10.00 per share obtained in connection with the entry into the Merger Agreement, and certain other customary closing conditions stated in the Merger Agreement. www.businesswire.com
C
by AlenCiken
Ameren Signs Long-Term 900 MHz Spectrum LeasesAmeren Signs Long-Term 900 MHz Spectrum Leases for Illinois & Missouri Service Territories Anterix (NASDAQ: ATEX) today announced its first long-term 900 MHz broadband spectrum lease agreements, covering Ameren Corporation's ("Ameren") service territories for 30 years. These agreements enable Ameren's deployment of a private LTE network to support its digital transformation to deliver benefits for millions of Ameren customers in Illinois and Missouri. finance.yahoo.com
NASDAQ:ATEX
by AlenCiken
Katapult to Become a Publicly Traded Company Through MergerKatapult to Become a Publicly Traded Company Through Merger With FinServ Acquisition Corp. Leading e-commerce focused point-of-sale platform for nonprime consumers Transaction values Katapult at a pro forma enterprise value of approximately $1 billion and equity value of $962 million, representing EV/EBITDA multiples of 14.1x and 6.6x projected EBITDA for 2021 and 2022, respectively. Total consideration paid to Katapult’s existing shareholders will be $833 million. Cash proceeds of the transaction will fund up to $325 million of cash consideration to Katapult’s existing shareholders and $50 million of cash to Katapult’s balance sheet. The cash components of the transaction will be funded by FinServ’s cash in trust of $250 million Transaction includes a $150 million fully committed PIPE at $10 per share from investors led by Tiger Global Management & Neuberger Berman Funds Attractive, profitable financial profile with approximately $250 million of projected revenue (+172% y/y) for 2020 Proven and experienced management team, who will continue leading the combined company The transaction is expected to close during the first half of 2021 www.businesswire.com
F
by AlenCiken
CURO Positioned to Benefit from Katapult’s Merger with FSRVCURO Group Holdings Corp. Positioned to Benefit from Katapult’s Announced Merger with FinServ Acquisition Corp. $900+ million Transaction Provides $365 million Total Consideration to CURO Katapult Holding, Inc. ("Katapult"), a company approximately 40% owned by CURO and a leading provider of e-commerce point-of-sale ("POS") lease purchase options for non-prime US consumers, and FinServ Acquisition Corp. (Nasdaq: FSRV) ("FinServ"), a publicly traded special purpose acquisition company ("SPAC"), have entered into a definitive merger agreement. The transaction values Katapult’s equity at $908 million, which includes an earnout of up to $75 million in the form of additional common shares in the new public company. Based on CURO’s ownership in Katapult, the transaction announced today will provide consideration consisting of a combination of cash and stock in the new company to CURO of $365 million , which includes an earnout of up to $30 million in the form of additional common shares in the new public company. To date, CURO has made a total cash investment in Katapult of $27.5 million. Upon the closing of the transaction, CURO anticipates receiving cash of up to $125 million and maintaining an ownership stake of at least 21% of the fully-diluted shares of the new public company. The transaction is expected to close during the first half of 2021 and remains subject to approval by FinServ stockholders and other customary closing conditions. finance.yahoo.com
C
by AlenCiken
Innoviz Technologies to be Listed on Nasdaq Through CGROInnoviz Technologies, a Global Leader in LiDAR Sensors and Perception Software for Autonomous Driving, to be Listed on Nasdaq Through Business Combination with Collective Growth Corporation - Transaction is expected to provide up to $350 million in gross proceeds comprised of Collective Growth's $150 million of cash held in trust, assuming no redemptions by public stockholders, and a $200 million fully committed ordinary share PIPE at $10.00 per share, led by Antara Capital and includes strategic investments from Magna International, Innoviz's Tier-1 partner, Phoenix Insurance and other institutional investors - Following the targeted closing of the transaction in the first quarter of 2021 , the combined Company is expected to have an estimated equity value of approximately $1.4 billion and to be listed on NASDAQ under the ticker symbol "INVZ" BMW chose Innoviz's solid-state LiDAR sensor, InnovizOne, sourced and manufactured by Magna International, to develop its LiDAR for series production - Innoviz current partners and investors include Magna International, Samsung-Harman, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, Phoenix Insurance, China Merchants Capital, Shenzhen Capital Group, Harel Insurance Investments and Financial Services and others finance.yahoo.com
CLong
by AlenCiken
Nvidia long position ongoing. Hello traders. Just wanted to share an ongoing Nvidia trade with opportunity to still enter before market reopen. Working the H1 time frame here on this stock using a follow trend script. Nvidia is a great example of how the script I'm using can be used on stocks if you operate on lower time frames to catch the ups and downs needed for working those lower time frames. On this stock I'm using the script to work to a stop loss and take profit target. Back test data is show at the bottom of screen on three years worth of data. For anymore information please drop me a message.
NASDAQ:NVDALong
by RichScott
Options Delta ExplainedI’m Markus Heitkoetter and I’ve been an active trader for over 20 years. I often see people who start trading and expect their accounts to explode, based on promises and hype they see in ads and e-mails. They start trading and realize it doesn’t work this way. The purpose of these articles is to show you the trading strategies and tools that I personally use to trade my own account so that you can grow your own account systematically. Real money…real trades. What is Delta? What is Delta? You see options prices are influenced by what they call the Greeks. A few of the Greeks are Delta, Gamma, and Theta. These are just three of the Greeks there are more. When you’re trading options, it is important that you know about the Greeks and what they do. For this article, we will focus on Delta, what it is, and why you should know exactly what Delta is. Then we’ll go through a specific example explaining it, and then I’ll share with you a few things that you need to know about Delta. So let’s get started. The Greeks OK, so as I mentioned, there are the option Greeks. Here are a few of them and what they tell you: 1) Delta is actually measuring the sensitivity. It’s a mouthful, but I’ll show you exactly what it means, for the option’s premium relative to the underlying asset in this article. In a nutshell, though, it basically says, how much does the option price change if the stock moves $1 to the upside or the downside? 2) Gamma is the rate of change of the Delta. 3) Theta , and Theta basically measures time decay. What Is Delta? So what is Delta? Delta is a number between 0 and 1 that measures how much the price of an option changes if the stock moves by $1. I know all of this sounds super theoretical, so let me actually give you a specific example. Now, the example that I want to use here is Microsoft MSFT when it was trading at $211.20. I want to cover different strike prices of options, because, again, options have strike prices and expirations. We are looking at the current price of this option and we will look at the new price of this option if MSFT moves by $1 from $211.20 to $212.20. When you bring up the option chain in your trading platform, in my case I use Tastyworks, the option we are using as an example is expiring on November 27th. Here, you would see there are different call options on this site with different strike prices. You would also see that they have all sorts of different Deltas. So let’s get started with the 205 that is right now trading at $7.30, and the Delta is 0.8. Remember, the Delta is 0.8 because again, the Delta is between 0 and 1. I’ll tell you about negative Delta in just a moment. The current price of the option is what we are seeing right here. We look at the last traded price, the last traded price is $6.92. So what does it mean? It means if MSFT goes up by $1 to $212.20, that the new price is $6.92 plus the Delta ($0.80). So, you see this where it’s really important that you understand Delta. Some people think that options move even more than the stock, and this is not true at all. So option prices always move less than the stock price. So the new price here of the option would then be $7.72. So this is for a strike price of 205, and this is a strike price that is so-called ITM “In The Money” because its value, its strike is less than the current price. Now let’s take a look at a strike that is at the money. Now assuming MSFT is trading at $211 we will use the 210 strike price. The 210 strike price has a Delta of 0.57, and this would be a so-called ATM “At The Money” with a Delta of 0.57. Again, it is between 0 and 1. The current price of the 210 strike here is $3.05. We are using the last traded price here. So if MSFT moves by $1 upwards, this option only moves 0.57. So this means that this option moves to $3.62. Lets cover one more example. So if we are using a strike of 215, that would be OTM “Out Of The Money,” and the Delta is 0.27. So the current price of this option is $1.06. So if the stock moves up by a dollar, this option only moves up by $0.27. Even though the stock moves up by $1, this only moves to $1.33. Things You Need To Know So let’s talk about the things you need to know. Options that are ITM have a higher Delta then options OTM. So this means that ITM options move more. Now, if you were to look back at your options chain, you see that the Delta for deep in the money options is 0.98. So this basically means that if the stock goes up by $1, the price of this option goes up by $0.98, so the deeper in the money, the closer to $1 the price will move. So options that are ITM are more expensive. This is where it’s important that you see that there’s a relationship between the Delta and the price. The higher the Delta, the higher the price, because the higher the Delta, the more it is in the money. As a rule of thumb, options ATM “At The Money” which are right where the strike price is right at the level where the current price is, are usually around 0.5. Now, all this applies to call options. Now put options have a negative Delta which is between -1 and 0. Well, the price of a put decreases if the option goes up. So the Delta for put options is all negative. Now, put options that are ATM, are usually closer to one. And options that are OTM, don’t move a whole lot. This is very important because some people just think, “Oh, my gosh, I’m buying out of the money options because they are cheap. It is so much cheaper to pay $1.6 than $6.92.” But they don’t really move a whole lot. Now here’s a really cool tip that you might not have known. The Delta is a rough estimate of the probability of the stock price closing above the strike. So here, you see with a delta of 0.8, it means that there’s an 80% probability right now that the stock will be above that strike price. If the Delta is 0.27, then that means there’s a 27% probability that the stock will be above that strike price. So I think it’s kind of cool as an options trader to know this. So the Delta is giving you a rough approximation of how likely is it that the stock will be above or below the current strike price on exploration. Now here’s the tricky part, Delta is not fixed. So the Delta changes as the price changes and here’s why. Right now, if, for example, MSFT (trading at $211) goes up to 215, the current strike price of 210 is deeper in the money therefore, then the Delta will be higher. So now you know what Delta is, how it influences the option price, and you see that this is important when you are trading options.
TVC:NDQ
by rockwelltrading
Genius Sports Group To Go Public Through Combination With DMYDGenius Sports Group To Go Public Through Combination With NYSE-Listed dMY Technology Group II - Pro forma enterprise value of the merger of approximately $1.5 billion, or 8.0x GSG's currently projected 2021 revenue of $190 million. - Transaction includes a $330 million fully committed private investment ("PIPE") at $10.00 per share. anchored by institutional and experienced industry investors - The combined company is expected to have approximately $150 million of growth capital (assuming no redemptions) and a substantially debt-free balance sheet to accelerate its U.S. and international expansion through organic growth and strategic acquisitions - dMY II shareholders, GSG shareholders and PIPE investors will hold shares in NYSE-listed combined company The Boards of Directors of both dMY II and GSG have unanimously approved the transaction. The transaction will require the approval of dMY II's stockholders, and is subject to other customary closing conditions, including a minimum cash condition. The transaction is expected to close in Q1 2021. finance.yahoo.com
D
by AlenCiken
HydraFacial and Vesper Healthcare Announce Business CombinationHydraFacial, an Experiential Beauty Health Company, and Vesper Healthcare Announce Business Combination HydraFacial is a category-creating beauty health company that provides a platform and technology to a community of providers and consumers, to deliver an experiential, 30-minute facial that offers results similar to a medical treatment Transaction values HydraFacial at an enterprise value of $1.1 billion. Following the transaction, the company expects to have $100M in cash and no debt The purchase price consists of $975 million payable at closing and up to $75 million payable upon the completion of certain identified acquisitions by the combined company. Top-tier institutional investors anchoring the fully committed $350 million PIPE include Fidelity Management & Research Company, LLC, Redmile Group, LLC, Principal Global Investors, LLC, Camber Capital Management and Woodline Partners LP Linden Capital Partners, a leading private equity firm, will remain the Company’s largest shareholder. The transaction, which has been unanimously approved by both Vesper Healthcare’s and HydraFacial’s boards of directors, is expected to close in the first half of 2021 and is subject to approval by Vesper Healthcare’s shareholders and other customary closing conditions, including any applicable regulatory approvals. finance.yahoo.com
V
by AlenCiken